VitMode

Ashwagandha and Male Fertility: What Did the Clinical Trial on Sperm Quality Show?

Ashwagandha is best known for lowering stress and cortisol, but a small Indian clinical trial tested something different: whether the same adaptogen could improve semen parameters in men with reduced sperm quality. The numbers from this pilot RCT are impressive — the question is how much can really be concluded from them.

PZdr Piotr ZielińskiAugust 25, 202611 min read
Table of contents

An adaptogen known for stress — but does it also affect fertility?

Ashwagandha (Withania somnifera) is today one of the most popular adaptogens, and its best-documented effect concerns lowering cortisol levels and subjective stress — a topic we cover in more depth in our entry on ashwagandha and cortisol. Far less discussed is another, narrower use of this herb: its possible effect on semen parameters in men with reduced semen quality, known as oligospermia.

The male factor accounts for roughly half of all cases of couple infertility, as we discuss in more detail in our knowledge-base entry on male fertility. It's in this context that one specific clinical trial is worth a closer look — the first to directly test the effect of ashwagandha on the semen analysis itself, not just on hormone levels or perceived stress.

This article is based on a single, specific study — an Indian pilot RCT from 2013. We deliberately avoid stacking citations from various, weaker sources here: we focus on the single best available study of this particular use and honestly show what it actually demonstrates, and what it doesn't.

What exactly was studied

Clinical Evaluation of the Spermatogenic Activity of the Root Extract of Ashwagandha (Withania somnifera) in Oligospermic Males: A Pilot Study

Early-stage evidence

Ambiye VR, Langade D, Dongre S, Aptikar P, Kulkarni M, Dongre A · Evidence-Based Complementary and Alternative Medicine · 2013

This pilot randomized trial included 46 men with a reduced sperm count (oligospermia): 21 received a full-spectrum ashwagandha root extract (675 mg/day in three doses) for 90 days, and 25 received placebo. In the ashwagandha group, sperm count increased by 167% (from 9.59 ± 4.37 to 25.61 ± 8.6 million/mL; p<0.0001), semen volume increased by 53% (from 1.74 ± 0.58 to 2.76 ± 0.60 mL; p<0.0001), and sperm motility increased by 57% (from 18.62 ± 6.11% to 29.19 ± 6.31%; p<0.0001). In the placebo group, improvement in these parameters was minimal, and serum sex hormone levels showed significantly greater and more favorable regulation in the treatment group.

View study

The scale of these numbers is striking — a near-tripling of sperm count in 90 days is a far larger result than most lifestyle interventions described in the male fertility literature. It's worth noting something easy to overlook, though: the authors themselves called their study a "pilot study" right in the title — that's not incidental, but an honest caveat about how much weight these results should be given, which we return to later in the article.

How ashwagandha might affect spermatogenesis — hypotheses, not certainties

The study's authors didn't directly investigate the mechanism behind the observed improvement, so the explanations circulating in the literature are hypotheses, not confirmed biochemical pathways. Three directions come up most often: ashwagandha's antioxidant properties, which could protect sperm from oxidative damage (one of the recognized mechanisms behind reduced semen quality); its well-documented cortisol-lowering effect, since excess cortisol can disrupt the hypothalamic-pituitary-gonadal axis; and its ability, observed in some studies, to moderately raise testosterone levels.

The mechanism remains unexplained

Research hypothesis

None of these three hypotheses was directly verified in this particular study — the authors measured the end result (semen parameters and hormones), not the pathway that led to it. It's worth clearly distinguishing this: we have a solid, numerical clinical result here, but the mechanistic "why" still awaits dedicated research.

This was a pilot study — what that really means

Limitations worth knowing before drawing conclusions

  • Small sample — 46 participants in total (21 in the treatment group) is enough to detect a large effect, but too small to rule out the role of chance or the specific characteristics of this particular group of men
  • A single-center study, conducted at one clinic in India — it's unknown whether the result would repeat in a different population, with a different diet, climate, or baseline health status
  • The population consisted exclusively of men with already diagnosed oligospermia — the study says nothing about whether ashwagandha would improve anything in men with normal, average semen parameters
  • A short, 90-day observation period — there's no data on whether the improvement persists, deepens, or reverses with longer use or after stopping it
  • The study measured semen analysis parameters, not real fertility outcomes — the number of pregnancies, live births, or time to conception in participants' partners

None of these caveats means the result is false or worthless — a randomized, placebo-controlled pilot RCT is a sturdier design than many popular "studies" cited in supplement marketing. It does mean, though, that this is a promising signal requiring confirmation in a larger, multi-center trial, not a final piece of evidence ready to be repeated uncritically in headlines.

Who the results apply to, and who they may not

Myth

Since the study showed such a large effect, ashwagandha will work similarly for any man who wants to "boost" his fertility.

Fact

The study included exclusively men with already confirmed, reduced sperm counts (oligospermia). It's unknown whether a man with normal baseline semen parameters would see any additional improvement from supplementation — that's an entirely different research question this particular study doesn't answer.

This distinction has practical significance: if semen parameters are already normal, there's no basis for expecting the effect from this study to repeat. Ashwagandha makes sense as something worth considering primarily for men with already diagnosed, reduced semen quality — after a semen analysis has been performed, not "just in case" without any diagnostics.

What's worth doing in practice

Practical takeaways for couples planning pregnancy

  • A semen analysis is the foundation — without it, there's no way to know whether semen parameters need improving in the first place
  • With confirmed oligospermia, it's worth discussing a full workup of the underlying cause (hormonal, structural, lifestyle-related) with a doctor before reaching for supplementation
  • Because of the full sperm production cycle (roughly 64-72 days), the effects of any intervention — including ashwagandha — won't be visible before 2-3 months of consistent use
  • It's worth remembering that modifiable lifestyle factors (body weight, smoking, chronic stress, scrotal overheating) have well-documented effects on semen quality regardless of any supplementation
  • A decision to supplement is worth discussing with a doctor, especially alongside other medications or coexisting thyroid conditions, since ashwagandha can interact with thyroid function

What this study doesn't prove

The limits of what we know

This single, small pilot study doesn't prove that ashwagandha increases the chance of conceiving a child, shortens the time trying to conceive, or that the effect persists beyond the 90-day observation period. It's also unknown whether a similar result would be obtained with a different dose, a different extract (the ashwagandha supplement market is highly inconsistent in terms of standardization), or in a different ethnic and climatic group than the Indian population studied. The results shouldn't replace a full workup of the causes of reduced semen quality or a consultation with a fertility specialist.

QuestionShort answer
Did ashwagandha improve semen parameters in this study?Yes — a significant increase in count, motility, and volume in men with oligospermia (n=21, 90 days)
Is this a large, definitive study?No — it's a pilot RCT with 46 participants, requiring confirmation in a larger sample
Does it apply to men with normal semen parameters?Unknown — only men with already diagnosed oligospermia were studied
Was an increase in pregnancies or live births proven?No — semen analysis parameters were measured, not hard fertility outcomes
When does the effect become visible?Not before 2-3 months, consistent with the sperm production cycle

Ashwagandha and semen quality at a glance

Our editorial recommendation

This study's result is too large numerically and too well designed methodologically (randomization, placebo, blinding) to ignore, but also too small in sample size and too narrow in population to treat as definitive proof. It's exactly the kind of signal that justifies further, larger studies — and one that may be worth considering for a man with already confirmed, reduced semen quality, but not as a universal "for fertility" recommendation for everyone.

One well-designed, small study isn't the same as proof — it's an invitation to ask the same question at a larger scale. Until then, it's worth balancing enthusiasm about these numbers with awareness of just how narrow the group was in which they were obtained.

Dr. Piotr Zieliński, VitMode editorial team

Frequently asked questions

The study lasted 90 days, and participants in the treatment group took 675 mg of full-spectrum ashwagandha root extract daily, split into three doses.

Exclusively to men with already diagnosed oligospermia, meaning a reduced sperm count. The study didn't test the effect in men with normal semen parameters, so conclusions shouldn't be drawn for that group.

No — the study measured semen analysis parameters (count, motility, and volume), not actual fertility outcomes such as the number of pregnancies or live births in participants' partners.

The authors themselves used this term in the title, signaling that it's a preliminary study with a small sample (46 people), intended to demonstrate the case for a larger, confirmatory trial — not to provide definitive proof.

In the study, assessment was carried out after 90 days of use, which roughly corresponds to the length of a full cycle of new sperm production (spermatogenesis) — a shorter observation period likely wouldn't capture the full effect.

No significant adverse effects were reported in the study described here, but ashwagandha can interact with certain medications (including thyroid medications) and shouldn't be used without medical consultation, especially with coexisting conditions or other medications.

Yes — without a baseline test, there's no way to assess whether semen parameters need improving at all, or later to verify whether supplementation had any effect for that specific person.

Sources

PZ

dr Piotr Zieliński

Specialist physician in endocrinology, scientific consultant

Piotr reviews content on hormones, metabolic health and supplement pharmacology.

Related articles

Related knowledge base entries

Ziołowe suplementy w proszku na marmurowym blacie4.6

Ashwagandha

One of the best-studied adaptogens — standardized extracts have been shown in clinical trials to lower perceived stress and cortisol levels.

AdaptogenyModerate evidence
Lekarz ze stetoskopem badający uśmiechniętego pacjenta w gabinecie4.4

Male Fertility and Semen Quality

A widely cited 2017 meta-analysis showed a decades-long decline in sperm counts in Western countries — we look at what's actually known about the factors affecting male fertility.

Zdrowie mężczyznModerate evidence
Umięśniony sportowiec w stroju treningowym4.7

Testosterone

The primary anabolic hormone — its natural level depends heavily on sleep, resistance training, body composition and fat mass.

HormonyStrong evidence
Lekarz mierzący ciśnienie krwi pacjenta w gabinecie4.7

TRT — Side Effects and Therapy Monitoring

Erythrocytosis, fertility impact, PSA screening, and the cardiovascular risk question — what testosterone replacement therapy safety actually involves and how it's monitored.

TRTStrong evidence
Lekarz w białym fartuchu podczas konsultacji medycznej online4.7

TRT (Testosterone Replacement Therapy) — What Is It and Who Is It For?

TRT isn't a supplement for fatigue — it's pharmacological treatment for a confirmed testosterone deficiency, with a real but limited list of benefits and an equally real list of people who simply don't qualify for it.

TRTModerate evidence
Próbki krwi w probówkach na jasnym tle laboratoryjnym4.7

What Tests Are Needed Before TRT? The Complete Pre-Treatment Testing List

Before a physician can qualify a patient for testosterone therapy, a far broader panel of tests is needed than testosterone level alone. The full list of blood tests, symptom questionnaires, and criteria that determine whether TRT is safe and appropriate.

TRTStrong evidence

Comments (2)

  • KW

    Kasia W. 2 weeks ago

    Very clearly explained, especially the interactions section — I hadn't seen it laid out this well anywhere else.

  • MT

    Marek T. a month ago

    Are you planning to update this with the newest study from this year? I saw an interesting meta-analysis.